Kayne Anderson Rudnick Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$662	Sell	2 -1	-33%	-$340	﹤0.01%	880
2025 Q4	$1.44K	Buy	3 +1	+50%	+$443	﹤0.01%	847
2025 Q3	$1.23K	Sell	2 -3	-60%	-$1.22K	﹤0.01%	865
2025 Q2	$1.86K	Buy	+5	New	+$1.38K	﹤0.01%	858
2025 Q1	–	Sell	-4	Closed	-$1.07K	–	966
2024 Q4	$1.07K	Buy	+4	New	+$1.05K	﹤0.01%	878
2024 Q2	–	Sell	-4	Closed	-$598	–	999
2024 Q1	$598	Hold	4	–	–	﹤0.01%	897
2023 Q4	$766	Hold	4	–	–	﹤0.01%	856
2023 Q3	$708	Hold	4	–	–	﹤0.01%	767
2023 Q2	$760	Buy	+4	New	+$793	﹤0.01%	771
2022 Q2	–	Sell	-9	Closed	-$1K	–	603
2022 Q1	$1K	Buy	+9	New	+$1.37K	﹤0.01%	615
2021 Q1	–	Sell	-6	Closed	-$1K	–	564
2020 Q4	$1K	Buy	+6	New	+$801	﹤0.01%	566